Sector Expert: James Joyce
Jim Joyce is the founder of Exosome Sciences and founder, chairman and CEO of Aethlon Medical (AEMD:NASDAQ), which maintains majority ownership in Exosome Sciences. Under Joyce's leadership, Aethlon pioneered the creation of affinity biofiltration devices to treat life-threatening diseases. Time magazine recently named the Aethlon Hemopurifier® to be one of the "Top 25 Inventions" and one of "11 Remarkable Advances in Healthcare" based on the Hemopurifier's ability to address a broad-spectrum of viral pathogens, including the successful treatment of Ebola virus. In the field of exosome biology, Joyce has co-authored exosome-related publications and is co-inventor on exosome-specific patent submissions. Prior to founding Exosome Sciences and Aethlon Medical, he was managing director at James Joyce & Associates, founder and CEO of Mission Labs, Inc. and was a member of the Denver Broncos Football Club of the National Football League. Joyce is a graduate of the University of Maryland.